Gene: AFAP1L2
Official Full Name: actin filament associated protein 1 like 2provided by HGNC
Gene Summary: Enables SH2 domain binding activity; SH3 domain binding activity; and protein tyrosine kinase activator activity. Involved in several processes, including positive regulation of epidermal growth factor receptor signaling pathway; regulation of gene expression; and regulation of mitotic cell cycle. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24761 | AFAP1L2 Knockout cell line (HeLa) | Human | AFAP1L2 | 1:3~1:6 | Negative | Online Inquiry |
KO24762 | AFAP1L2 Knockout cell line (A549) | Human | AFAP1L2 | 1:3~1:4 | Negative | Online Inquiry |
AFAP1L2 Gene Knockout Cell Lines are specially engineered cellular models in which the AFAP1L2 gene has been completely disrupted, allowing researchers to investigate the functional implications of this specific gene's absence. These knockout cell lines are invaluable tools for studying the roles of AFAP1L2 in various biological pathways and diseases, where protein expression and function are critical for cellular processes.
Key functions of the AFAP1L2 gene include its involvement in actin filament dynamics, cell adhesion, and signal transduction pathways. By utilizing these knockout cell lines, researchers can elucidate how the loss of AFAP1L2 affects cellular morphology, migration, and response to external stimuli, thereby shedding light on its potential implications in cancer metastasis and other pathologies.
The scientific importance of AFAP1L2 Gene Knockout Cell Lines extends beyond basic research. In clinical settings, they can be valuable for drug discovery and development, allowing for the identification of therapeutic targets and the screening of potential compounds that can rescue the dysfunctional pathways initiated by the absence of AFAP1L2. These models facilitate the understanding of genetic contributions to disease, paving the path for novel treatment strategies.
What sets our AFAP1L2 Gene Knockout Cell Lines apart from alternatives is the precision of our gene-editing techniques, ensuring that the knockout is specific and validated for consistent reproducibility in experiments. This high level of reliability is crucial for researchers looking to publish or advance their findings with confidence.
For researchers and clinicians, investing in AFAP1L2 Gene Knockout Cell Lines offers a significant competitive advantage, providing clarity on the molecular mechanisms underpinning diseases linked to AFAP1L2 dysregulation. These cell lines not only enhance the robustness of research projects but also accelerate the translation of discoveries into real-world applications.
With our extensive expertise in genetic engineering and commitment to delivering high-quality biological products, we ensure that our AFAP1L2 Gene Knockout Cell Lines meet the rigorous demands of the scientific community, empowering you to unlock new insights in your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.